Pathology Analysis & Statistics, May 2013 (p50)

Talk to Amrita

+1 718 303 2019

Search inside this page

Publishers

All regions

You might be interested in: cancer, breast cancer, prostate cancer, more »

1471-1520 of about 5 600 reports

Purchase Reports From Reputable Market Research Publishers

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge ...

  • Industries : Pathology
  • Countries : China, World, Spain, Italy, France, Germany, United States, Canada, India, Europe
Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will ...

  • Industries : Pathology
  • Countries : Canada, World, Spain, Italy, France, Germany, United States, United Kingdom, India, China, Europe
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Crohn's Disease - Current and Future Players

PharmaPoint: Crohn's Disease - Current and Future Players

  • $ 2 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Crohn's Disease - Current and Future Players”. The report is a vital source ...

  • Industries : Pathology
  • Countries : World
Physician Views: How do Indian oncologists plan to use biosimilar Herceptin?

Physician Views: How do Indian oncologists plan to use biosimilar Herceptin?

  • $ 645
  • Industry report
  • January 2014
  • by Firstword Pharma

Scope Biocon's CANMAb - a biosimilar version of Roche's HER2-positive breast cancer treatment Herceptin (trastuzumab) - is to launch on the Indian market in the first week of February. Kiran Mazumdar-Shaw ...

  • Industries : Pathology
  • Countries : India
Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Genzyme Corporation (Genzyme) is a biotechnology company which is principally engaged in developing and applying technologies in the life sciences to encounter unmet deadly diseases. Its products and ...

  • Industries : Pathology
  • Countries : United States, Ireland
Sinclair Pharma Plc (SPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sinclair Pharma Plc (SPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Sinclair IS Pharma PLC (Sinclair) is a pharmaceutical company. The company develops pharmaceuticals in the therapeutic areas of dermatology, wound care and oral health. The company's products include ...

  • Industries : Pathology
OXiGENE, Inc. (OXGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OXiGENE, Inc. (OXGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary OXiGENE, Inc. (Oxigene) is a clinical-stage biopharmaceutical company. The company develops therapeutics to treat cancer and eye diseases. It develops anti-vascular drugs such as vascular disrupting ...

  • Industries : Pathology
  • Countries : United States
Immune Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immune Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Immune Pharmaceuticals Ltd (Immune Pharmaceuticals) is a biopharmaceutical company. The company develops and markets monoclonal antibodies for the treatment of inflammatory diseases and cancer. ...

  • Industries : Pathology
2014 Assessments of Leading Infectious Disease Market Players--Insightful Profiles of Major Suppliers and Emerging Market Entrants

2014 Assessments of Leading Infectious Disease Market Players--Insightful Profiles of Major Suppliers and Emerging Market Entrants

  • $ 2 450
  • Industry report
  • January 2014
  • by Venture Planning Group

This new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic ...

  • Industries : Pathology
Celator Pharmaceuticals, Inc. (CLPM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celator Pharmaceuticals, Inc. (CLPM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Celator Pharmaceuticals, Inc. (Celator) is a pharmaceutical company. The company develops and distributes therapies for the treatment of cancer. Its products include CPX-351 Liposome injection, ...

  • Industries : Pathology
  • Countries : United States
H. Lee Moffitt Cancer Center & Research Institute - Medical Equipment - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary H. Lee Moffitt Cancer Center & Research Institute (Moffitt) is a healthcare service providing company. The company provides cancer prevention and cure services. Its services include screening and ...

  • Industries : Pathology
  • Countries : United States
VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2013 Update

VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary VolitionRX Ltd. (VolitionRX) is a life sciences company. The company provides non invasive blood tests for cancer. It provides products such as NuQ and HyperGenomics. The company's NuQ is based ...

  • Industries : Pathology
Narhex Life Sciences Limited (Symbol:NLS) SWOT Analysis, Strategy, Revenues and Profits

Narhex Life Sciences Limited (Symbol:NLS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : World
Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Almirall Hermal GmbH SWOT Analysis, Strategy, Revenues and Profits

Almirall Hermal GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Almirall Hermal GmbH (Almirall) is a pharmaceutical company engaged in research, development, production and distribution of dermatological drugs. It is an operating unit of Almirall pharmaceutical company, ...

  • Industries : Pathology
Civatech Oncology Inc. - Product Pipeline Analysis, 2013 Update

Civatech Oncology Inc. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary Civatech Oncology Inc. (Civatech) is a medical device company. The company develops novel polymer based devices for the treatment of cancer using localized, low-dose-rate radiation. It offers products ...

  • Industries : Pathology
  • Countries : United States
Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
C2N Diagnostics LLC - Product Pipeline Analysis, 2013 Update

C2N Diagnostics LLC - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary C2N Diagnostics LLC (C2N Diagnostics) is a biotechnology service provider. The company develops tools and assays for clinical drug development, pre-clinical drug discovery and the early detection ...

  • Industries : Pathology
  • Countries : United States
iSonea Limited (ISN) - Financial and Strategic SWOT Analysis Review

iSonea Limited (ISN) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

iSonea Limited (ISN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pathology
Neurotrek, Inc. - Product Pipeline Analysis, 2013 Update

Neurotrek, Inc. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary Neurotrek, Inc. (Neurotrek) is a biotechnology company. The company develops and offers U+, a targeted, non-invasive neuromodulation technology. Its U+ is a proprietary platform which uses ultrasound ...

  • Industries : Pathology
  • Countries : United States
Navotek Medical Ltd. - Product Pipeline Analysis, 2013 Update

Navotek Medical Ltd. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary Navotek Medical Ltd. (Navotek) is an intra-body tracking technologies developer. The company provides RealEye, a fiducial-based patient positioning and realtime target monitoring system for radiation ...

  • Industries : Pathology
  • Countries : Israel
Pathology: IntegraGen S.A (ALINT)

Pathology: IntegraGen S.A (ALINT)

  • $ 750
  • Company report
  • January 2014
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the IntegraGen S.A portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Pathology
  • Countries : France
NovaScan, LLC - Product Pipeline Analysis, 2013 Update

NovaScan, LLC - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary NovaScan, LLC (NovaScan) is a medical technology company. The company's technology measures the electrical properties of materials. It specializes in designing apparatus to detect breast cance ...

  • Industries : Pathology
  • Countries : United States
Pathology: Miraculins Inc. (MOM)

Pathology: Miraculins Inc. (MOM)

  • $ 750
  • Company report
  • January 2014
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Miraculins Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Pathology
Medical Equipment and Supply: Cyberonics, Inc. (CYBX)

Medical Equipment and Supply: Cyberonics, Inc. (CYBX)

  • $ 750
  • Company report
  • January 2014
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Cyberonics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Pathology
  • Countries : United States
Ministry of Health, New Zealand - Strategic SWOT Analysis Review

Ministry of Health, New Zealand - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Ministry of Health, New Zealand - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Pathology
  • Countries : New Zealand
Insightra Medical Inc. - Product Pipeline Analysis, 2013 Update

Insightra Medical Inc. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • January 2014
  • by Global Data

Summary Insightra Medical, Inc. (Insightra Medical) is a medical device company. The company manufactures medical devices in the areas of cardiology, surgery, endoscopy, and urology. It offers products ...

  • Industries : Pathology
  • Countries : United States
Advanced in the Rheumatoid Arthritis Market

Advanced in the Rheumatoid Arthritis Market

  • $ 1 741
  • Industry report
  • January 2014
  • by Espicom Business Intelligence

Rheumatoid arthritis (RA) is a chronic disorder for which there is currently no cure It affects around 23 5 million adults in the world (WHO, 2013) and approximately 294,000 children under the age of ...

  • Industries : Pathology
  • Countries : Japan, United States, Russian Federation, Europe, India, China
Global Amyotrophic Lateral Sclerosis Market 2014-2018

Global Amyotrophic Lateral Sclerosis Market 2014-2018

  • $ 2 000
  • Industry report
  • January 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Amyotrophic Lateral Sclerosis Drugs Market to grow at a CAGR of 5.39 percent over the period 2013-2018. One of the key factors contributing to this market growth ...

  • Industries : Pathology
  • Countries : World
About 38 000 reports

Download Unlimited Documents from Trusted Public Sources

Global Pathology Description

  • Health-e Bytes™
  • August 2014
    10 pages
  • Hepatitis  

  • World  

    Europe  

View report >

About 200 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.